Common Side Effects of Bovine Colostrum
Bovine colostrum supplements may cause mild gastrointestinal side effects including bloating, nausea, and diarrhea, especially when starting higher doses. These effects are reported most often in new users and typically subside as the body adjusts to the supplement. People with lactose sensitivity may experience amplified symptoms because colostrum contains small amounts of milk sugars and proteins. The FDA does not approve bovine colostrum as a drug, and supplements are regulated as food, which means side effect tracking relies on voluntary reports and company disclosures. Some brands publish third-party testing results on their websites to show purity and contaminant levels. For more on supplement regulation, see the FDA overview at FDA Dietary Supplements Guidance.
Allergic reactions are another documented side effect, particularly for individuals allergic to cow's milk. Symptoms can range from hives and itching to more severe responses like difficulty breathing in rare cases. A 2023 review of bovine colostrum safety noted that immunoglobulin content can trigger immune-mediated responses in sensitive populations. The European Food Safety Authority has published assessments on bovine-derived ingredients that highlight allergen risks. Consumers with known milk allergies should consult a healthcare provider before using colostrum products. Additional context on allergen labeling can be found at FDA Allergen Labeling Rules.
Drug Interactions and Specific Population Risks
Bovine colostrum may interact with immunosuppressant drugs because of its immunoglobulin and growth factor content. Patients on medications for autoimmune conditions or after organ transplants should exercise caution and discuss colostrum use with their physician. Some studies suggest that bioactive peptides in colostrum can modulate cytokine pathways, potentially altering drug metabolism. The National Institutes of Health Office of Dietary Supplements provides fact sheets on interactions between supplements and prescription medications. For a detailed interaction database, visit the NIH Office of Dietary Supplements at NIH ODS Supplement Fact Sheets.
Pregnant and breastfeeding women are advised to avoid bovine colostrum supplements due to insufficient safety data. Hormonal components such as insulin-like growth factor 1 (IGF-1) are present in colostrum and could theoretically affect fetal development or milk production. The American College of Obstetricians and Gynecologists recommends that pregnant individuals consult their care team before taking any new supplement. Children and elderly populations with compromised immune systems also fall into higher-risk categories for adverse reactions. For guidance on supplement use during pregnancy, see the ACOG patient resources at ACOG Women's Health Resources.
Quality Control, Contamination, and Regulatory Gaps
Contamination with heavy metals, bacteria, or pesticides is a documented risk for bovine colostrum sourced from regions with weak quality controls. Third-party testing by organizations such as NSF International and USP helps verify that products meet label claims for purity and potency. Some manufacturers voluntarily adopt Current Good Manufacturing Practices (cGMP) to reduce contamination risks, but compliance is not universal across the industry. The Global Dairy Platform publishes standards for colostrum collection and processing that aim to minimize safety hazards. For more on cGMP requirements, see the FDA guidance at FDA cGMP for Dietary Supplements.
Rankings of top-selling colostrum brands on e-commerce platforms often highlight price and capsule count but rarely disclose side effect profiles or